News and Announcements
Mastering the Art of Raising Capital: Patience, Diligence, and the Journey to Venture Capital Success
- Published April 16, 2023 11:00PM UTC
- Publisher Jade Miguel
- Categories Capital Raising Tips
As founders, we often approach our ventures with impatience, optimism, and confidence. However, the reality of raising capital can be a harsh wake-up call.
Initially, we envision investors eagerly investing in our amazing business or idea. After all, we are our own biggest fans, having invested significant time and energy into our projects. However, the capital raising process often exposes the flaws in our businesses, leading to a continuous cycle of rejection. Some founders may start to self-destruct or blame others for their inability to secure venture capital.
The truth is, raising capital is rarely a quick process. It requires patience, diligence, and a methodological approach. Sometimes, investors may only decide to invest after several years of knowing about your business. They wait for specific milestones that move them from being fence-sitters to committed investors.
However, there are instances where investors commit after just one phone call. This is often due to years of hard work, dedication, visibility, strategic communication, and an investor-friendly capital-raising process aligning with their investment thesis.
It’s essential to remember that 90% to 99% of investors may not be interested in your business. Your goal is to find the 1 to 10% who will. To succeed in raising capital, consider these six principles:
- Be diligent and persistent in your capital raising efforts.
- Maintain visibility and create your own serendipity.
- Aim to attract 50 investors to your deal room within the first two months.
- Communicate with potential investors 4 to 12 times per year.
- Understand that more people are watching your progress than you may
Capital Raising Tips
The Biofilm Breakthrough: How An Australian BioTech Firm Is Tapping Indonesia’s $45,000-a-Kitchen Bottleneck
Australian sustainability and deep-tech firm Altair International Pty Ltd is commercialising plant-based clinical hygiene technology, targeting a prime operational bottleneck in Indonesia’s massive national free meals program. Every few years, an Australian deep-tech company emerges combining proprietary science with a transformational anchor contract, the kind of business that quietly creates an entirely new market category […]
THE TAX CHANGED. NOW THE PRODUCT IS CHANGING TO MATCH.
Changes to the 50% capital gains tax discount are shifting Australian private capital away from growth and into high-yielding wrappers. Fund managers are actively redesigning products across private credit and property to capture the incoming capital rotation
The Algorithm Re-Dosing Cancer Treatment: Inside the University of Melbourne Spin-Out Rewriting a 60-Year-Old Formula
Oncology specialists are still calculating toxic chemotherapy doses using a formula from the era of the Ford Model T, leading to a system where seven out of eight patients are routinely overdosed. University of Melbourne spin-out PredicTx is dismantling this legacy approach, utilizing advanced AI to analyze existing patient CT scans, deliver precision medicine to the bedside, and return a massive 100x financial rerate to hospital networks.
Backed By Leading Investment Groups and Family Offices
